Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results Article

Kutuk, Tugce, Tolakanahalli, Ranjini, McAllister, Nicole C et al. (2022). Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results . 14(12), 10.3390/cancers14122946

Open Access

cited authors

  • Kutuk, Tugce; Tolakanahalli, Ranjini; McAllister, Nicole C; Hall, Matthew D; Tom, Martin C; Rubens, Muni; Appel, Haley; Gutierrez, Alonso N; Odia, Yazmin; Mohler, Alexander; Ahluwalia, Manmeet S; Mehta, Minesh P; Kotecha, Rupesh

sustainable development goals

authors

publication date

  • June 1, 2022

keywords

  • BEVACIZUMAB
  • CNS malignancies
  • GLIOBLASTOMA
  • HYPERSENSITIVITY
  • Life Sciences & Biomedicine
  • Oncology
  • PATTERNS
  • PHASE-III
  • PRDR
  • RADIATION-THERAPY
  • REIRRADIATION
  • RETREATMENT STRATEGY
  • SURVIVAL
  • Science & Technology
  • TEMOZOLOMIDE
  • glioma
  • pulsed reduced dose rate radiotherapy
  • re-irradiation
  • recurrence

Digital Object Identifier (DOI)

publisher

  • MDPI

volume

  • 14

issue

  • 12